Michaut, Magali
Chin, Suet-Feung
Majewski, Ian
Severson, Tesa M.
Bismeijer, Tycho
de Koning, Leanne
Peeters, Justine K.
Schouten, Philip C.
Rueda, Oscar M.
Bosma, Astrid J.
Tarrant, Finbarr
Fan, Yue
He, Beilei
Xue, Zheng
Mittempergher, Lorenza
Kluin, Roelof J.C.
Heijmans, Jeroen
Snel, Mireille
Pereira, Bernard
Schlicker, Andreas
Provenzano, Elena
Ali, Hamid Raza
Gaber, Alexander
O’Hurley, Gillian
Lehn, Sophie
Muris, Jettie J.F.
Wesseling, Jelle
Kay, Elaine
Sammut, Stephen John
Bardwell, Helen A.
Barbet, Aurélie S.
Bard, Floriane
Lecerf, Caroline
O’Connor, Darran P.
Vis, Daniël J.
Benes, Cyril H.
McDermott, Ultan
Garnett, Mathew J.
Simon, Iris M.
Jirström, Karin
Dubois, Thierry
Linn, Sabine C.
Gallagher, William M.
Wessels, Lodewyk F.A.
Caldas, Carlos
Bernards, Rene
Article History
Received: 23 July 2015
Accepted: 19 November 2015
First Online: 5 January 2016
Competing interests
: W.M.G. is a co-founder and Chief Scientific Officer of OncoMark Limited. J.K.P., J.H., M.S. and I.M.S. received salary from Agendia as employee (no stocks or other funding). R.B. is employee and shareholder of Agendia. M.M., T.B., L.F.A.W. and R.B. are inventors on a patent about the ILC subtypes presented in this study.